Previous 10 | Next 10 |
home / stock / numi:cc / numi:cc news
The modern psychoactive renaissance is continuing to gain momentum, with Alberta becoming the latest region to propose regulatory changes regarding the substances. On October 5, Government officials declared that Alberta will be the first province in Canada to regulate psychoa...
Numinus Wellness Inc. Reports Q4 2022 and Annual Results Canada NewsWire Q4 2022 revenues grew 643% year-over-year to $4.2 million Q4 2022 gross margin grew to 31.5%, generated $1.3 million of gross profit Completed acquisition of Novamind, po...
Psychoactive medicine has come a long way in the last couple of years and is not slowing down anytime soon. Gone are the days when hallucinogens conjured up images of tie-dye T-shirts and peace signs. The psychoactive renaissance taking place right now is fueled by governments, science, c...
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022 Canada NewsWire VANCOUVER, BC , Nov. 22, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health car...
Numinus to Host Q4 and Year End 2022 Results Conference Call on November 29, 2022 PR Newswire VANCOUVER, BC , Nov. 15, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care compan...
Numinus Re-Launches "Psychedelic Therapy Frontiers" Podcast with additional hosts and topics Canada NewsWire Series is Devoted to Exploring The Psychedelic Renaissance and Cultivating a Healthy Mind, Body and Spirit VANCOUVER, BC , Nov. 1, 2022 ...
Numinus to Participate in Wonderland: Miami on November 3-5, 2022 Canada NewsWire VANCOUVER, BC , Oct. 31, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treat...
Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness Canada NewsWire Clinical program broadens access to ketamine-assisted therapy for an underserved population VANCOUVER, BC , Oct. 28, 2022 /CNW/ - Numinus Welln...
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022 Canada NewsWire VANCOUVER, BC , Oct. 7, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care ...
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical study using the Company’s unique psychedelic molecul...
News, Short Squeeze, Breakout and More Instantly...
Numinus Wellness Inc. Company Name:
NUMI:CC Stock Symbol:
TSXC Market:
Numinus Wellness Inc. Website:
Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results Canada NewsWire Q3 Fiscal 2024 Highlights Revenue of $4.3 million , a 1.9% decline over Q2 2024 Gross profit of $1.0 million , a 9.8% decline over Q2 2024 Cash position of $3.7 million ...
Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 Canada NewsWire VANCOUVER, BC , July 10, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing tradition...
Numinus Wellness Announces Resignation of Director Canada NewsWire VANCOUVER, BC , June 24, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional a...